Eton Pharmaceuticals Inc. (ETON)
NASDAQ · Healthcare
Eton Pharmaceuticals Inc. Revenue 2019–2025
Eton Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Eton Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 24.3 M, a 40.41% increase year-over-year.
- Eton Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 82.9 M, a 141.15% increase year-over-year.
- Eton Pharmaceuticals Inc. annual revenue for 2025 was 80.0 M, a 104.94% increase from 2024.
- Eton Pharmaceuticals Inc. annual revenue for 2024 was 39.0 M, a 23.29% increase from 2023.
- Eton Pharmaceuticals Inc. annual revenue for 2023 was 31.6 M, a 48.90% increase from 2022.
- Eton Pharmaceuticals Inc. annual revenue for 2022 was 21.3 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eton Pharmaceuticals Inc. Market Cap — FAQ
Eton Pharmaceuticals Inc. (ETON) market cap over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ETON's market cap history?
The chart and table above show Eton Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.